Searchable abstracts of presentations at key conferences in endocrinology

ea0011s60 | Steroid hormone receptors | ECE2006

Cell membrane receptors of steroid hormones

Brosens J , Huhtaniemi I , Gellersen B

Rapid activation of diverse signal transduction pathways is thought to play an integral role in the cellular responses to many steroid hormones, including progesterone. This sex steroid is essential for normal reproduction in nearly all species. The recent cloning of a G-protein coupled receptor with the properties of a membrane progestin receptor (mPR) in fish and the subsequent identification of three mammalian homologues (mPR-alpha, -beta, and -gamma) raised the possibility...

ea0011p17 | Bone | ECE2006

Hearing impairment increases risk of bone fractures in women with Turner’s syndome

Han TS , Conway GS , Cadge B

Aims: To assess factors associated with excess rates of fractures in women with Turner’s syndrome.Settings: Adult Turner Clinic.Outcome measures: Bone fracture history, oestrogen, growth hormone, oxandrolone and thyroxine therapies, anthropometry, calcium, vitamin D, parathyroid hormone and karyotype, hearing impairment, spinal bone mineral density (BMD). This study was approved by Ethical Committee.Resu...

ea0011p72 | Clinical case reports | ECE2006

Regression of somatotropinoma in the course of treatment with octreotide in a female patient with acromegaly

Matuszek B , Lenart-Lipiska M , Nowakowski A

Long-acting somatostatin analogs are now increasingly being prescribed as adjuvant and primary therapy for the treatment of acromegaly. Many studies have shown them to be both effective and safe, by suppressing GH levels and normalizing serum IGF-1 levels in most cases.The aim of the study was to analyze the case report of a female patient with active acromegaly and evaluate the efficacy of long-acting synthetic analog of somatostatin (Sandostatin LAR) for biochemical control ...

ea0011p87 | Clinical case reports | ECE2006

Gitelman’s syndrome in pregnant, type 1 diabetic patient presented with foetal growth retardation, and bilateral hydronephrosis and hydroureter

Elrishi MA , Kilvert A , Sirnivasan B , Lawrence I

Gitelman’s syndrome (GS) is an autosomal recessive primary renal tubular disorder with hypokalemic metabolic alkalosis, hypocalciuria, and magnesium deficiency. The association of GS and type 1 diabetes is rare1, and bilateral hydronephrosis and hydroureter has not been reported.A 18-year-old female with known GS diagnosed at 17 years of age and type 1 diabetes diagnosed at 15 years of age was admitted to Leicester Royal Infirmary for pre...

ea0011p139 | Clinical case reports | ECE2006

Multihormonal disorders in 17 year old girl with congenital hypoplastic anemia and secondary hemochromatosis

Glab E , Wikiera B , Barg E

Congenital hypoplastic anemia (Diamond-Blakfan Syndrom) is genetically determined disorder which is manifested in early childhood with selective deficiency of erythrocyte line in bone marrow. Severe anemia usually appears between 2nd and 6th month of life. Survival depends on blood transfusions, which in consequence lead to hemosiderosis. Hypopituitarism, hypogonadism and diabetes mellitus and other endocrinopathies are the complications of hemochromatosis.<p class="abstex...

ea0011p173 | Clinical case reports | ECE2006

Pretibial Myxoedema: Is this a marker for occult thyroid ophthalmopathy?

Bhattacharya B , Ullah A , McCulloch AJ , Heald AH

Introduction: Thyroid eye disease affects an estimated 400,000 people in the UK and for a sizeable minority this is an extremely unpleasant condition. Radioactive iodine treatment with I131 for thyrotoxicosis can cause sight-threatening flare-up of dysthyroid eye disease. Patients with dysthyroid eye signs should undergo specialist ophthalmology assessment prior to administration of I131.Case history: A 56 year old gentleman presented with symptoms of th...

ea0011p582 | Neuroendocrinology and behaviour | ECE2006

Hypopituitary patients have a high occurrence of metabolic syndrome markers and an increased prevalence of cardiovascular risk factors

Matuszek B , Obel E , Kowalczyk M , Nowakowski A

Introduction: Hypopituitary patients receiving conventional hormone substitution, but without GH replacement, have an increased mortality from cardiovascular diseases. Inadequate hormone replacement is a possible cause of this increased mortality. GH deficiency in adult patients has been associated with several cardiovascular risk factors, including hyperlipidemia, increased abdominal adiposity, and impaired insulin sensitivity.Aim of the study: The aim ...

ea0057031 | TSH receptor-blocking autoantibodies: the pregnancy paradigm | BES2018

TSH receptor-blocking autoantibodies: the pregnancy paradigm

Martens P-J , Polders C , Decallonne B

Background: Graves’ disease (GD) is an autoimmune disease caused by antibodies directed to the TSH receptor (TRAb), which can be activating (TSAb), neutral, or blocking (TBAb). This balance determines the final clinical result. Typically TSAbs dominate, resulting in hyperthyroidism. Rarely, TBAbs prevail and result in hypothyroidism (1). The TRAb assay routinely used in the clinic does not allow to differentiate between stimulating or blocking characteristics.<p class...

ea0010p85 | Steroids to include Cushing's | SFE2005

Adrenalectomy for hypercortisolism

Girardin E , Verges B , Brun J

Aim of the study: to analyze surgical outcome in patients who underwent unilateral or bilateral adrenalectomy for hypercortisolism.Methods: retrospective study including patients operated on between January 1994 and June 2005.Results: adrenalectomies for hypercortisolism were performed in 18 patients (5 males, 13 females, mean age 43.6±16.1 years). Indications were cortisol producing adenoma (n=10), adrenocortical carcinoma (n...

ea0009p14 | Diabetes and metabolism | BES2005

Effects of hormone replacement therapy and raloxifene on C-reactive protein in healthy postmenopausal women

Kumru S , Yildiz M , Godekmerdan A , Yilmaz B

We have investigated the effects of estradiol valerat plus dienogest and raloxifene on serum high sensitive C - reactive protein (hsCRP) levels in healthy postmenopausal women. This study was approved by the local ethics committee. Forty eight healthy postmenopausal women were randomly divided into three groups. While group I (n=16) was given 60 mg raloxifene, group II (n=16) received continuously 2 mg estradiol valerat plus 2 mg dienogest. Group III (n=16) received no medicat...